FDA Inspection 1266388 — Covenant Medical Center
The FDA completed an inspection of Covenant Medical Center on Apr 3, 2025 in Lubbock, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 3, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lubbock, TX (United States)